发明授权
US5902576A Antitumor pharmaceutical composition comprising IL-6 transfected cells
失效
包含IL-6转染细胞的抗肿瘤药物组合物
- 专利标题： Antitumor pharmaceutical composition comprising IL-6 transfected cells
- 专利标题（中）： 包含IL-6转染细胞的抗肿瘤药物组合物
-
申请号： US430248申请日： 1995-04-28
-
公开(公告)号： US5902576A公开(公告)日： 1999-05-11
- 发明人: Lea Eisenbach , Angel Porgador , Michael Feldman , Michel Revel
- 申请人： Lea Eisenbach , Angel Porgador , Michael Feldman , Michel Revel
- 申请人地址： ILX Rehovot
- 专利权人： YEDA Research and Development Co. Ltd. at Weizmann Institute of Science
- 当前专利权人： YEDA Research and Development Co. Ltd. at Weizmann Institute of Science
- 当前专利权人地址： ILX Rehovot
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K48/00 ; C12N5/00
摘要：
An anti-tumor pharmaceutical composition includes cells into which a gene encoding human IL-6 has been inserted. A method of treatment of a patient suffering from cancer to prevent and/or inhibit the development of metastases by administering to the patient the anti-tumor pharmaceutical composition including the above mentioned cells.
公开/授权文献
- US5004089A Clutch driven plates and method of producing the same 公开/授权日：1991-04-02
信息查询
